Peptide Atlas · Mineral

Iron dextran

In 688,183 Medicare patients given intravenous iron, the risk of anaphylaxis at first exposure was 68 per 100,000 for iron dextran against 24 per 100,000 for the non-dextran products combined.

established

provisional
2 citations
0 discussions
0 followers
Cosmofer
Dexferrum
INFeD
high/low molecular weight iron dextran
iron(III)-dextran complex

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- emerging
  Claim: Low-molecular-weight iron dextran and iron sucrose have similar safety profiles in CKD (review) standing
- resolved
Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.
Auerbach M, Al Talib K
pmid 18274543
- established
  Claim: Iron dextran carries the highest anaphylaxis risk among intravenous iron products (Medicare cohort) standing
- resolved
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Wang C, Graham DJ, Kane RC, Xie D, Wernecke M, Levenson M, MaCurdy TE, Houstoun M, Ryan Q, Wong S, Mott K, Sheu TC, Limb S, Worrall C, Kelman JA, Reichman ME
pmid 26575062

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.